期刊文献+

原发性肝癌肝移植36例临床分析 被引量:2

Clinical Analysis of 36 Cases of Primary Hepatocellular Carcinoma with Liver Transplantation
下载PDF
导出
摘要 目的 探讨原位肝移植在原发性肝癌治疗中的意义。方法 回顾性分析 2 0 0 1年 10月至 2 0 0 3年 8月肝癌肝移植 3 6例的临床病例资料。结果 围手术期死亡率为 0 ;经术前辅助治疗肿瘤直径缩小者 12例 ;术后生存 3~ 6个月者 7例 ( 19.4% ) ,生存 6~ 12个月 10例 ( 2 7.8% ) ,生存 >12个月 19例 ( 5 2 .8% ) ,最长生存 15个月 ,平均生存期为 8.5个月 ,7例晚期肝癌平均生存期4.5月 ,均于术后 3~ 6个月内复发。结论 严格选择肝癌病例并通过术前辅助治疗降低肿瘤分期可提高肝移植效果 ; Objective To investigate the significance of orthotopic liver transplantation(OLT) in the management of primary hepatocellular carcinoma(PHC).Methods Clinical and following-up data of 36 cases of PHC undertook OLT were analysed retrospectively.Results Perioperational mortality rate was zero;preoperational auxiliary therapy can succeed in reducing the size of tumor in 12 cases,24 cases lives longer than 6 months and 19 cases longer than 12 months,the mean survival span was 8.5 month,while advanced PHCs reoccurred within 3~6 months and the mean survival span was 4.5 month.Conclusion Strict selection of receipts and efficacious auxiliary therapy show a beneficial effect on patient survival;The relation between tumor reoccurrence and postoperational chemotherapy and immunosuppression awaits further study.
出处 《实用癌症杂志》 2004年第1期59-61,共3页 The Practical Journal of Cancer
关键词 原发性肝癌 肝移植 临床分析 适应证 辅助治疗 Primary Hepatocellular Carcinoma Orthotopic Liver Transplantation Indication Auxiliary therapy
  • 相关文献

参考文献9

  • 1Carlis L, Giacomoni A, Lauterio A, et al. Liver transplantation for hepatocellular cancer:should the current indication criteria be changed? [J]. Transpl Int, 2003, 16 (2)115.
  • 2Stippel DL, Kasper HU, Schleimer K, et al. Underestimation of nodules while staging hepatocellular carcinoma prior to neoadjuvant treatment on waiting list for transplantation[J ]. Transplant Proc ,2003,35(4) :1423.
  • 3Gondolesi G, Munoz L, Matsumoto C, et al. Hepatocellular carcinoma:a prime indication for living donor liver transplantation[] ]. ] Gastrointest Surg ,2002,6( 1 ) : 102.
  • 4Bolondi L, Piscaglia F, Camaggi V, et al. Review article: liver transplantation for HCC. Treatment oplions on the wailing lisl [J ], Alimem Pharmacol Ther, 2003,17 ( suppl 2) : 145.
  • 5Graziadei lW, Sandnmeller H, Waldenberger P, et al . Chemoembolization followed by liver lransplantation for hepatocellular carcinoma impedes lumor progression while on the waiting list and leads to excellent outcome[J]. Liver Transpl, 2003,9(6) : 557.
  • 6Panis Y ,Ribeiro J ,Chrelien Y ,et al. Dormant liver metastases :an experimental study [ J ]. Br J Surg, 1992,79 (6) :221.
  • 7Vivarelli M,Bellusci R, Cucchetti A,et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation : beuer patient seleclion or lower immunosuppression? [J]. Transplantation, 2002,74(12) :1746.
  • 8Kairemo K, Lindahl H, Merenmies J, et al. Anti-alpha-fetoprotein imaging is useful for staging hepatoblastoma[J].Transplantation, 2002,73 (7) : 1151.
  • 9Lemoine A, Le-BriconT, Salvucci M, et al. Prospective evaluation of circulaling hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery[J]. Ann Surg, 1997,226 ( 1 ) :43.

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部